MedTrace Logo

Systematic Screening for COPD in Tabacology Consultation

NCT04843605 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 112

Last updated 2024-08-12

No results posted yet for this study

Summary

COPD is a very common disease, an estimated 3 million people are affected in France. Unfortunately, this pathology is under-diagnosed. Several reasons can be mentioned: the banality of the symptoms or the several comorbidities.

Screening faces a major difficulty: the realization of a spirometry. Various studies have shown the complexity of the implementation of mass screening in cities by mini-spirometry.

The COPD World Health Days allow this mass screening but without visibility on the actual entry into a care pathway.

The objective of this study is to assess the impact of systematic screening for COPD during a tabacology consultation

Conditions

  • Smoking Cessation

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Principal Investigators

  • Marc Beaumont, PhD · CH des pays de Morlaix

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-16
Primary Completion
2023-08-01
Completion
2023-08-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04843605 on ClinicalTrials.gov